|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||148.47 - 152.71|
|52 Week Range||86.20 - 168.96|
|Beta (5Y Monthly)||0.95|
|PE Ratio (TTM)||37.83|
|Forward Dividend & Yield||1.72 (1.10%)|
|Ex-Dividend Date||May 21, 2020|
|1y Target Est||N/A|
The list celebrates 50 inspirational women who are not yet senior leaders in an organisation but are making a significant contribution to gender diversity at work.
Snowflake blew some minds on Wall Street with its red-hot IPO. Yahoo Finance speaks with Snowflake CEO Frank Slootman about the road ahead.
German biotechnology firm Curevac expects to be able to produce the COVID-19 vaccine it is developing at scale by the end of the year, investor Dietmar Hopp told the Handelsblatt business daily on Friday. "We want to make 100 million doses available by the end of the year," said billionaire Hopp, one of the founders of software company SAP. Curevac is likely to be beaten to market by U.S. rival Moderna and Germany's Biontech.